Literature DB >> 19301050

Changes in chromatic pattern-onset VEP with full-body inversion.

Jennifer Highsmith1, Michael A Crognale.   

Abstract

PURPOSE: Intra-ocular pressure (IOP) increases to double that of its normal level under full-body inversion, in part simulating high IOPs found in glaucoma and ocular hypertension. Inversion also simulates negative g-forces experienced in aerobatic maneuvers such as those produced during aerial combat. Studies using achromatic pattern-reversal visual evoked potentials (VEPs) have shown losses in response amplitude when subjects are inverted and IOP is increased. In other studies, chromatic, pattern-onset VEPs have been shown to be a sensitive and objective indicator of ocular and systemic pathology. Thus, chromatic pattern-onset VEPs may also show changes in amplitude and/or latency when subjects are subjected to full-body inversion.
METHODS: In this study we employed chromatic, pattern-onset VEPs to determine if there were changes in response latency for the different visual pathways with healthy subjects during full-body inversion. Stimuli were 1 cpd horizontal sine-wave patterns presented in an onset mode (100 ms on/400 ms off). Subjects (n = 7) were tested at low to medium contrast levels, which were subjectively equated across chromatic pathways (S, LM, and achromatic). Patterns were presented using LCD goggles.
RESULTS: All subjects showed a small but statistically significant increase in latency in the large negative component (CII) for both L - M and S - (L + M) pathways during inversion. The achromatic pathway also showed a statistically significant increase in latency to the positive component (CI) during inversion.
CONCLUSIONS: These results demonstrate that changes in ocular and/or systemic physiology during full-body inversion can result in increased latencies of chromatic and achromatic pattern-onset VEPs.

Entities:  

Mesh:

Year:  2009        PMID: 19301050     DOI: 10.1007/s10633-009-9170-0

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  29 in total

1.  Comparison of color and luminance contrast: apples versus oranges?

Authors:  E Switkes; M A Crognale
Journal:  Vision Res       Date:  1999-05       Impact factor: 1.886

2.  Separable evoked retinal and cortical potentials from each major visual pathway: preliminary results.

Authors:  T A Berninger; G B Arden; C R Hogg; T Frumkes
Journal:  Br J Ophthalmol       Date:  1989-07       Impact factor: 4.638

3.  Simulation of spaceflight with whole-body head-down tilt: influence on intraocular pressure and retinocortical processing.

Authors:  B J Linder; G L Trick
Journal:  Aviat Space Environ Med       Date:  1987-09

4.  Postural variations of intraocular pressure--preflight experiments for the D1-mission.

Authors:  J Draeger; K Hanke
Journal:  Ophthalmic Res       Date:  1986       Impact factor: 2.892

5.  Blue and green cone mechanisms in retinitis pigmentosa.

Authors:  M A Sandberg; E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-02       Impact factor: 4.799

Review 6.  The vascular concept of glaucoma.

Authors:  J Flammer
Journal:  Surv Ophthalmol       Date:  1994-05       Impact factor: 6.048

7.  Optic nerve dysfunction during gravity inversion. Pattern reversal visual evoked potentials.

Authors:  T R Friberg; G Sanborn
Journal:  Arch Ophthalmol       Date:  1985-11

8.  Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis.

Authors:  V Porciatti; F Sartucci
Journal:  Brain       Date:  1996-06       Impact factor: 13.501

9.  Effect of inverted body position on intraocular pressure.

Authors:  R N Weinreb; J Cook; T R Friberg
Journal:  Am J Ophthalmol       Date:  1984-12-15       Impact factor: 5.258

10.  Color vision in the tritan axis is predominantly affected at high altitude.

Authors:  Manca Tekavcic-Pompe; Igor Tekavcic
Journal:  High Alt Med Biol       Date:  2008       Impact factor: 1.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.